BIO-key International (NASDAQ:BKYI) versus mPhase Technologies (OTCMKTS:XDSL) Head-To-Head Review

BIO-key International (NASDAQ:BKYIGet Free Report) and mPhase Technologies (OTCMKTS:XDSLGet Free Report) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Earnings & Valuation

This table compares BIO-key International and mPhase Technologies’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BIO-key International $8.59 million 0.15 -$11.91 million ($16.55) -0.10
mPhase Technologies $30.67 million 0.00 $1.67 million N/A N/A

mPhase Technologies has higher revenue and earnings than BIO-key International.

Analyst Recommendations

This is a summary of current ratings for BIO-key International and mPhase Technologies, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International 0 0 0 0 N/A
mPhase Technologies 0 0 0 0 N/A

Profitability

This table compares BIO-key International and mPhase Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BIO-key International -90.82% -136.97% -56.41%
mPhase Technologies N/A N/A N/A

Risk and Volatility

BIO-key International has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, mPhase Technologies has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500.

Institutional & Insider Ownership

26.5% of BIO-key International shares are held by institutional investors. 13.7% of BIO-key International shares are held by insiders. Comparatively, 47.2% of mPhase Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

mPhase Technologies beats BIO-key International on 6 of the 9 factors compared between the two stocks.

About BIO-key International

(Get Free Report)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

About mPhase Technologies

(Get Free Report)

mPhase Technologies, Inc. provides artificial intelligence and machine learning focused technology products and related services. It offers mPower EV Charging Network; and Consumer Engagement Platform to understand behavior patterns of consumers and allows the retailers to make these just in time offers available to the end consumer as they travel. mPhase Technologies, Inc. was founded in 1979 and is headquartered in Rockville, Maryland.

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.